ZBTB32 and cholangiocarcinoma: When the survival analysis was carried out using two selected signatures, we found that CC patients with high expression of both ZBTB32 and CENPS had a more distinct tendency to get more OS time than those with low expression, and more significant than analyses of a single FARG (p < 0.001; Figure 6H).